STUDIO

Prolevi Bio's CEO Sahil Gupta in BioStock's studio

Prolevi Bio on the financing round and focus for 2023

Privately held Prolevi Bio aims improve treatment for many patients suffering from hypoterosis. The company has developed a method that is to improve the drug...

RECOMMENDED READING

Annexin cancer shares issue

Annexin’s CEO: “The cancer area more than doubles the potential”

Annexin Pharmaceuticals' candidate ANXV is being developed as a new treatment for retinal vein...
LS-klustret i Göteborg lyckat experiment

LS cluster in Gothenburg: a successful experiment

Life Science is an important sector for western Sweden's business community, and the life...

EVENT